Like many of its peers, including Boston Scientific and Johnson & Johnson, Medtronic's business has been impacted by procedure deferrals as healthcare systems around the world have deferred most elective procedures to focus on COVID-19.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,